Calming and Sleeping Market Overview in Australia

  • April 2014
  • -
  • Euromonitor International
  • -
  • 25 pages

Calming and sleeping products grew by 6% in current value during 2009, with sales reaching A$12 million. OTC calming and sleeping products, particularly herbal/traditional remedies, are still benefiting from the negative media coverage of prescription medications resulting from a highly publicised accidental overdose in the preceding year.

Euromonitor International's Calming and Sleeping Products in Australia report offers a comprehensive guide to the size and shape of the industry at a national level. It provides the latest retail sales data from 2005 to 2009 , allowing you to identify the segments driving growth. Projections to 2014 illustrate how the industry is set to change.

Product coverage:

Data coverage: indsutry size (historic and projections ), market shares , brand shares and distribution channel figures .

Reasons to Buy This Report
* Gain in-depth understanding of the Consumer Health market ;
* Identify areas of growth and understand key dynamics ;
* Get a full overview of the competitive landscape , the industry ’s major players and leading brands;
* Anticipate market change with 5 year forecasts .

Euromonitor International has over 30 years experience of publishing industry research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Table Of Contents

Calming and Sleeping in Australia

June 2010
List of Contents and Tables
Executive Summary
Consumer Health Maintained Steady Growth
H1n1 Influenza Rapidly Developed During the 2009 Winter
Sanofi-aventis Healthcare Pty Ltd Gained Leadership in Consumer Health
Grocery Retailers and Direct Selling Gained Distribution Share
Consumer Health Sales Growth Expected To Hold Steady Over the Projection Period
Key Trends and Developments
Consumer Health Spending Unabated by Economic Downturn
Fear of H1n1 Influenza Pandemic Facilitated Sales
Grocery Retailers Channel Intensifies Competition for Retail Distribution Share
National Preventative Health Strategy
Ageing Profile of Australian Consumers
Market Indicators
Data table 1 Consumer Expenditure on Health Goods and Medical Services from 2004 to 2009
Data table 2 Life Expectancy at Birth from 2004 to 2009
Market Data
Data table 3 Sales of Consumer Health by Segment : Value from 2004 to 2009
Data table 4 Sales of Consumer Health by Segment : % Value Growth from 2004 to 2009
Data table 5 Consumer Health Market Shares by Value from 2005 to 2009
Data table 6 Consumer Health Brand Shares by Value from 2006 to 2009
Data table 7 Penetration of Private Label by Segment from 2004 to 2009
Data table 8 Sales of Consumer Health by Distribution Format: % Analysis from 2004 to 2009
Data table 9 Sales of Consumer Health by Segment and Distribution Format: % Analysis 2009
Data table 10 Projection Sales of Consumer Health by Segment : Value from 2009 to 2014
Data table 11 Projection Sales of Consumer Health by Segment : % Value Growth from 2009 to 2014
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC Healthcare Switches from 2008 to 2009
Definitions
Sector and Subsector Definitions
Summary 2 Research Sources
Blackmores Ltd
Strategic Direction
Key Facts
Summary 3 Blackmores Ltd: Key Facts
Summary 4 Blackmores Ltd: Operational Indicators from 2007 to 2009
Company Background
Production
Summary 5 Blackmores Ltd: Production Statistics 2009
Competitive Positioning
Summary 6 Blackmores Ltd: Competitive Position 2009
Ego Pharmaceuticals Pty Ltd
Strategic Direction
Key Facts
Summary 7 Ego Pharmaceuticals Pty Ltd: Key Facts
Company Background
Production
Summary 8 Ego Pharmaceuticals Pty Ltd: Production Statistics 2009
Competitive Positioning
Summary 9 Ego Pharmaceuticals Pty Ltd: Competitive Position 2009
Herron Pharmaceuticals Pty Ltd
Strategic Direction
Key Facts
Summary 10 Herron Pharmaceuticals Pty Ltd: Key Facts
Company Background
Production
Summary 11 Herron Pharmaceuticals Pty Ltd: Production Statistics 2009
Competitive Positioning
Summary 12 Herron Pharmaceuticals Pty Ltd: Competitive Position 2009
Inova Pharmaceuticals (australia) Pty Ltd
Strategic Direction
Key Facts
Summary 13 iNova Pharmaceuticals (Australia) Pty Ltd: Key Facts
Company Background
Production
Summary 14 iNova Pharmaceuticals (Australia) Pty Ltd: Production Statistics 2009
Competitive Positioning
Summary 15 iNova Pharmaceuticals (Australia) Pty Ltd: Competitive Position 2009
Swisse Natural Health Products Pty Ltd
Strategic Direction
Key Facts
Summary 16 Swisse Natural Health Products Pty Ltd: Key Facts
Company Background
Production
Summary 17 Swisse Natural Health Products Pty Ltd: Production Statistics 2008
Competitive Positioning
Summary 18 Swisse Natural Health Products Pty Ltd: Competitive Position 2009
Trends
Category Data
Data table 12 Sales of Calming and Sleeping Products: Value from 2004 to 2009
Data table 13 Sales of Calming and Sleeping Products: % Value Growth from 2004 to 2009
Data table 14 Calming and Sleeping Products Market Shares by Value from 2005 to 2009
Data table 15 Calming and Sleeping Products Brand Shares by Value from 2006 to 2009
Data table 16 Projection Sales of Calming and Sleeping Products: Value from 2009 to 2014
Data table 17 Projection Sales of Calming and Sleeping Products: % Value Growth from 2009 to 2014

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Early Signals: future scenarios that will drive consumption and product innovation over the next five years

Early Signals: future scenarios that will drive consumption and product innovation over the next five years

  • $ 7 995
  • Industry report
  • September 2014
  • by Canadean Ltd

Summary “Early Signals: future scenarios that will drive consumption and product innovation over the next five years” provides a tool kit for understanding how tomorrow's market will differ from today's ...

FMCG Business Confidence Report Q3 2014

FMCG Business Confidence Report Q3 2014

  • $ 1 950
  • Industry report
  • September 2014
  • by Canadean Ltd

Summary “FMCG Business Confidence Report Q3 2014” is a new report by Canadean that globally analyzes industry opinions on the latest economic and consumer issues, and their impact on investment decisions ...

FMCG Business Confidence Report Q3 2014

FMCG Business Confidence Report Q3 2014

  • $ 1 950
  • Industry report
  • September 2014
  • by Canadean Ltd

Summary “FMCG Business Confidence Report Q3 2014” is a new report by Canadean that globally analyzes industry opinions on the latest economic and consumer issues, and their impact on investment decisions ...


Company Reports

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.